miR-2116-5p functions as a tumor suppressor in lung adenocarcinoma by targeting ADAM12 and serves as a prognostic biomarker
Hanxing Huang, Lihan Xiao, Min Xiao, Kaiying Chen, Shumei Chen, Ning Wu · 2026
Read miR-2116-5p functions as a tumor suppressor in lung adenocarcinoma by targeting ADAM12 and serves as a prognostic biomarker by Hanxing Huang, Lihan Xiao, Min Xiao, Kaiying Chen, Shumei Chen, Ning Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13576270.txt.
Description
Hanxing Huang and five colleagues study a tiny RNA that holds back lung adenocarcinoma, the most common lung cancer subtype, in a 2026 paper. The RNA, called miR-2116-5p, runs low in these tumours. The team asked whether its level predicts patient outcomes and how it acts inside cancer cells.
Tissue from 125 patients confirmed the low levels, which tied to lymph node spread and later disease stage. Patients with the lowest levels survived less well, and the RNA stood as an independent risk marker in survival models. Raising it in cells slowed growth, movement, and invasion, while lowering it did the reverse. Its direct target proved to be ADAM12, a protein whose rise cancelled the RNA's brake effect. The authors propose the RNA as both a prognosis marker and a treatment lead.
Catalog record
| CREATOR | Hanxing Huang, Lihan Xiao, Min Xiao, Kaiying Chen, Shumei Chen, Ning Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28094 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |